ArticleBMC cardiovascular disorders2026
Successful management of protracted anaphylaxis-induced severe acute respiratory distress syndrome masquerading as non-ST elevation myocardial infarction: a rare case report.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProlonged anaphylaxis, especially symptoms that last several days, can lead to misdiagnosis and delays in treatment, especially when patients present with complications such as acute respiratory distress syndrome (ARDS) and secondary myocardial injury. A thorough review of medical history is very important for accurate diagnosis. Early recognition and intervention are essential for managing both the allergic response and pulmonary-cardiac injury. CASE PRESENTATION: We present the case of a 70-year-old woman with no significant medical history who developed rapid respiratory failure and extremely elevated troponin levels. The patient was initially diagnosed with non-ST-segment elevation myocardial infarction (NSTEMI) complicated by pulmonary edema, and the patient's condition continued to worsen despite coronary intervention. A reevaluation revealed that anaphylaxis was potentially triggered by the recent use of floctafenine and meloxicam, which were taken as painkillers four days before admission. The administration of epinephrine led to a marked improvement in her condition, and she was successfully discharged without further complications.
conclusionProtracted anaphylaxis, especially when complicated by ARDS and myocardial injury mimicking NSTEMI, requires careful diagnostic consideration. Clinicians must thoroughly evaluate patient history, particularly recent medication use, to avoid misdiagnosis. Epinephrine remains a crucial treatment in such cases, and prompt administration can be life-saving. This case highlights the diagnostic challenges of protracted anaphylaxis and the importance of comprehensive clinical assessment and timely intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.